Asia accounted for almost 60% of the global incidence, mortality and five-year prevalence in 2020, with the highest incidence rates found in Australia and Eastern Asia for both sexes.
一家致力於推進新藥開發進程的國際性受託研究機構 (CRO) 和科學諮詢合作夥伴
立足臨床試驗,護航人類健康未來。
協同合作共進,科創驅動前行。
深耕產業標竿,鑄就卓越口碑。
深耕臨床科研數十載,引領產業發展標竿。
Asia accounted for almost 60% of the global incidence, mortality and five-year prevalence in 2020, with the highest incidence rates found in Australia and Eastern Asia for both sexes.